Viewing Study NCT05627960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-21 @ 8:35 AM
Study NCT ID: NCT05627960
Status: RECRUITING
Last Update Posted: 2022-11-28
First Post: 2022-03-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Sponsor: A&G Pharmaceutical Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
None Hormone-Resistant Breast Cancer View
None Non Small Cell Lung Cancer View
None Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Progranulin View
None Advanced solid malignancies View
None Phase 1 View
None Anti-Progranulin antibody View
None Advanced solid tumors View
None Breast Cancer View
None Lung Cancer View
None Mesothelioma View